OBIO Announces National Call to Canadian Health Science Companies for Applications for the 2021 OBIO Investment Summit
The 2021 OBIO Investment Summit national call for applications from health science companies that are seeking Series A or beyond investments is now open.
OBIO Announces First Eight Early Adopter Health Network Projects to Drive Innovation into the Health System
The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is proud to announce the launch of the first eight Early Adopter Health Network (EAHN™) innovation projects.
Flosonics Medical's FloPatch Featured on CBC The National
On CBC’s The National, Flosonics Medical and their FloPatch medical device were featured in a segment on how the technology can help wirelessly assess and monitor blood flow for critically ill patients, including those with COVID-19.
Steadiwear Wins Baylis Medical People's Choice Award at TiEQuest Business Competition
Steadiwear, an OBIO CAAP 2018 company, won the Baylis Medical People's Choice Award at the 16th Annual TiEQuest Business Competition.
OBIO Anti-Racism Statement
As millions around the world speak out against racism and its impact, OBIO, as an organization, is committed to anti-racism and to advancing racial equality through our continued growth as an organization.
IRCC Online Consultation on Immigration Levels and the Municipal Nominee Program
Immigration, Refugees and Citizenship Canada is conducting an online consultation and seeking input on Canada’s immigration levels plan, including the balance between different classes and programs, and how immigration can support Canada – particularly in light of the current pandemic.
Perimeter Medical Announces Completed Reverse Takeover, Stock Exchange Listing and Completed Financing Round
Perimeter Medical Imaging AI announced that a previously announced reverse take-over has been completed and, as a result, Perimeter will be listed on the TSX-V. In addition, Perimeter closed its previously announced $10-million financing round.
OBIO Roundtable on Governance – Blog on Key Points for Building and Managing a Board of Directors
On July 7th, OBIO held a Roundtable Discussion with health science companies on Governance. The Roundtable covered two practical aspects of governance - building and managing a BoD. This blog summarizes the key, take-home nuggets from the event.
OBIO’s Health to Business Bridge Program (H2BB) is Preparing the Future Leaders of Ontario’s Health Science Industry
OBIO’s Health to Business Bridge™ Program (H2BB) prepares new hires for careers in Ontario’s health science industry, helping companies build for the future in an innovative sector poised for growth.
OBIO Announces Early Adopter Health Network Call for Applications to Address COVID-19
This is a call to action for companies developing health technologies including COVID-19 management and treatment technologies to be evaluated for commercial readiness within its Early Adopter Health Network
OBIO's COVID-19 Advocacy Efforts
As the health science industry adjusts to the realities of COVID-19, OBIO continues to advocate and work on your behalf. Over the last two weeks, OBIO has engaged with health science companies in a variety of ways.
Ontario Government Announces Health Science Industry As Essential Business Sector
The Government of Ontario has announced that the health science industry is deemed an essential service in Ontario and will be exempted from temporary closures of businesses due to COVID-19.
Federal Government Announces New Supports for Business in Fight Against COVID-19
Today, the Government of Canada announced a plan to mobilize industry to combat COVID-19. The plan will redirect a variety of streams of government funding toward manufacturing, commercialization and research focused on health science products and services needed during the pandemic.
OBIO launches first Early Adopter Health Network in Ontario
The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization in Ontario, announce today’s launch of the province’s first-of-its-kind Early Adopter Health Network (EAHN). The EAHN is a network of health organizations that get leading-edge technologies into the health system.
Future of Health Care in Canada: OBIO Investment Summit Connects Global Investors, Leading-Edge Health Companies
Last week, 43 of the most promising companies in the Canadian health science industry came together at the OBIO Niagara Investment Summit, where they showcased their innovations to over 40 investors from across North America and Japan to pave the path to the investments needed to fully commercialize products.
RetiSpec wins iGan Partners' Pitch to Heal Event
RetiSpec was selected as the winner of iGan Partners’ annual Pitch to Heal Event.
OBIO at MedTech Conference in Boston
This year's AdvaMed MedTech Conference in Boston was a fantastic event. OBIO was in attendance for meetings and conversations with US and global investors and strategics about what's coming up for the health science industry in Canada. There was tons of enthusiasm and interest to capitalize on as we head into 2020.
FedDev Ontario announces $6.24 million investment in OBIO
FedDev Ontario is investing up to $6.24 million for the Ontario Bioscience Innovation Organization (OBIO®) to boost investment, market access and mentorship opportunities for companies across southern Ontario looking to commercialize their medical innovations.
Why Ontario needs a network of Early Adopter Health Organizations: Biotechnology Focus
In the latest issue of Biotechnology Focus, OBIO President and CEO Gail Garland contributed a special report: Why Ontario needs a network of Early Adopter Health Organizations
OBIO Announces Launch of OBIO CAAP® for 2019
The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2019 Capital Access Advisory Program (CAAP®) and the high-potential health science companies in this year’s program.